TY - JOUR
T1 - Comprehensive quantitative sensory testing shows altered sensory function in women with chronic pelvic pain
T2 - results from the Translational Research in Pelvic Pain (TRiPP) Study
AU - Coxon, Lydia
AU - Vollert, Jan
AU - Perro, Danielle
AU - Lunde, Claire E
AU - Ferreira-Gomes, Joana
AU - Charrua, Ana
AU - Abreu-Mendes, Pedro
AU - Krassowski, Michal
AU - Birch, Judy
AU - Meijlink, Jane
AU - Hummelshoj, Lone
AU - Hoffmann, Anja
AU - Aziz, Qasim
AU - Arendt-Nielsen, Lars
AU - Pogatzki-Zahn, Esther
AU - Evans, Emma
AU - Demetriou, Lysia
AU - McMahon, Stephen B
AU - Missmer, Stacey A
AU - Becker, Christian M
AU - Zondervan, Krina T
AU - Horne, Andrew W
AU - Cruz, Francisco
AU - Sieberg, Christine B
AU - Treede, Rolf-Detlef
AU - Nagel, Jens
AU - Vincent, Katy
N1 - Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the International Association for the Study of Pain.
PY - 2023/11/1
Y1 - 2023/11/1
N2 - Chronic pelvic pain (CPP), despite its high prevalence, is still relatively poorly understood mechanistically. This study, as part of the Translational Research in Pelvic Pain (TRiPP) project, has used a full quantitative sensory testing (QST) paradigm to profile n = 85 women with and without CPP (endometriosis or bladder pain specifically). We used the foot as a control site and abdomen as the test site. Across 5 diagnostically determined subgroups, we found features which are common across different aetiologies, eg, gain of function in pressure pain threshold (PPT) when assessing responses from the lower abdomen or pelvis (referred pain site). However, disease-specific phenotypes were also identified, eg, greater mechanical allodynia in endometriosis, despite there being large heterogeneities within diagnostic groups. The most common QST sensory phenotype was mechanical hyperalgesia (>50% across all the groups). A "healthy' sensory phenotype was seen in <7% of CPP participants. Specific QST measures correlated with sensory symptoms assessed by the painDETECT questionnaire (pressure-evoked pain [painDETECT] and PPT [QST] [r = 0.47, P < 0.001]; mechanical hyperalgesia (painDETECT) and mechanical pain sensitivity [MPS from QST] [r = 0.38, P = 0.009]). The data suggest that participants with CPP are sensitive to both deep tissue and cutaneous inputs, suggesting that central mechanisms may be important in this cohort. We also see phenotypes such as thermal hyperalgesia, which may be the result of peripheral mechanisms, such as irritable nociceptors. This highlights the importance of stratifying patients into clinically meaningful phenotypes, which may have implications for the development of better therapeutic strategies for CPP.
AB - Chronic pelvic pain (CPP), despite its high prevalence, is still relatively poorly understood mechanistically. This study, as part of the Translational Research in Pelvic Pain (TRiPP) project, has used a full quantitative sensory testing (QST) paradigm to profile n = 85 women with and without CPP (endometriosis or bladder pain specifically). We used the foot as a control site and abdomen as the test site. Across 5 diagnostically determined subgroups, we found features which are common across different aetiologies, eg, gain of function in pressure pain threshold (PPT) when assessing responses from the lower abdomen or pelvis (referred pain site). However, disease-specific phenotypes were also identified, eg, greater mechanical allodynia in endometriosis, despite there being large heterogeneities within diagnostic groups. The most common QST sensory phenotype was mechanical hyperalgesia (>50% across all the groups). A "healthy' sensory phenotype was seen in <7% of CPP participants. Specific QST measures correlated with sensory symptoms assessed by the painDETECT questionnaire (pressure-evoked pain [painDETECT] and PPT [QST] [r = 0.47, P < 0.001]; mechanical hyperalgesia (painDETECT) and mechanical pain sensitivity [MPS from QST] [r = 0.38, P = 0.009]). The data suggest that participants with CPP are sensitive to both deep tissue and cutaneous inputs, suggesting that central mechanisms may be important in this cohort. We also see phenotypes such as thermal hyperalgesia, which may be the result of peripheral mechanisms, such as irritable nociceptors. This highlights the importance of stratifying patients into clinically meaningful phenotypes, which may have implications for the development of better therapeutic strategies for CPP.
U2 - 10.1097/j.pain.0000000000002955
DO - 10.1097/j.pain.0000000000002955
M3 - Article
C2 - 37289573
SN - 1872-6623
VL - 164
SP - 2528
EP - 2539
JO - Pain
JF - Pain
IS - 11
ER -